
The funding will be for a GLP-1 receptor agonist clinical programme for weight loss

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment

The new centre will be home to nearly 2,000 world-class researchers and scientists

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

The results from a global phase 3 trial show the longest survival data ever reported in this setting

This is the first new regimen in more than a decade for first-line treatment for this type of breast cancer

There are currently no approved human vaccines for Lyme disease

The treatments are for eligible adults in England and Wales

Litfulo delivered significant, clinically meaningful improvements for both face and body

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

The phase 3 trial showed greater than 50% improvement in radiographic progression-free survival

The company will gain a novel oral treatment for lung cancer